We are live on ! Find out more
NXTC icon

NextCure
NXTC

39 hedge funds and large institutions have $16.6M invested in NextCure in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.13% less ownership

Funds ownership: 3.99% → 3.86% (-0.13%)

9% less funds holding

Funds holding: 43 → 39 (-4)

31% less capital invested

Capital invested by funds: $24M → $16.6M (-$7.34M)

46% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 13

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
39
Holders Change
-4
Holders Change %
-9.3%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
13
Closed
6
Calls
$38K
Puts
–
Net Calls
+$38K
Net Calls Change
-$70K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$72.1K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$27.2K
3
Millennium Management
Millennium Management
New York
+$21.5K
4
TRCT
Tower Research Capital (TRC)
New York
+$5.38K
5
Renaissance Technologies
Renaissance Technologies
New York
+$4.77K

Top Sellers

Rank Fund Capital Flow
1
CPA
Cardiff Park Advisors
California
-$472K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$126K
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$79.1K
4
BlackRock
BlackRock
New York
-$43.3K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$41.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$3.5M – – –
SI
2
Sofinnova Investments
California
$3.45M – – –
Millennium Management
3
Millennium Management
New York
$1.84M +$21.5K +1,125 +1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.17M -$8.01K -420 -0.6%
BlackRock
5
BlackRock
New York
$1.16M -$43.3K -2,268 -3%
LFCM
6
Long Focus Capital Management
Puerto Rico
$717K – – –
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$628K – – –
Citadel Advisors
8
Citadel Advisors
Florida
$566K +$72.1K +3,779 +12%
TCM
9
Tang Capital Management
California
$516K – – –
Federated Hermes
10
Federated Hermes
Pennsylvania
$473K -$191 -10 -0%
BCM
11
BML Capital Management
Indiana
$395K – – –
AI
12
Acuitas Investments
Washington
$370K -$38 -2 -0%
Renaissance Technologies
13
Renaissance Technologies
New York
$323K +$4.77K +250 +1%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$225K +$27.2K +1,427 +11%
DCM
15
DAFNA Capital Management
California
$214K -$34.2K -1,792 -11%
Macquarie Group
16
Macquarie Group
Australia
$194K – – –
SCM
17
Sio Capital Management
New York
$168K – – –
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$123K -$126K -6,601 -45%
BCM
19
Bridgeway Capital Management
Texas
$122K – – –
Barclays
20
Barclays
United Kingdom
$87.1K – – –
Two Sigma Advisers
21
Two Sigma Advisers
New York
$75.1K -$25.4K -1,333 -22%
State Street
22
State Street
Massachusetts
$73.6K – – –
Northern Trust
23
Northern Trust
Illinois
$55.5K -$725 -38 -1%
IC
24
IEQ Capital
California
$48.2K – – –
ECM
25
ExodusPoint Capital Management
New York
$26K -$16.3K -852 -33%
1
2

NXTC Hedge Fund Activity: Q3 2023 in Review

39 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q3 2023, worth a combined $16.6M — down 31% from $24M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of NXTC and 2 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 7 added.

The largest buyer was Citadel Advisors, adding an estimated $72.1K. The largest seller was Cardiff Park Advisors, exiting entirely with an estimated $472K sold.

  • 39 institutional investors held NextCure (NXTC) as of Q3 2023, down from 43 in Q2 2023.
  • Funds reported $16.6M of NextCure stock for Q3 2023, down 31% quarter-over-quarter.
  • 2 funds opened new NextCure positions in Q3 2023 and 6 closed out, a net change of -4 holders.
  • The largest NextCure buyer in Q3 2023 was Citadel Advisors, an estimated $72.1K added.
  • The largest NextCure seller in Q3 2023 was Cardiff Park Advisors, an estimated $472K sold.

Based on aggregated 13F filings for Q3 2023.